Status:
COMPLETED
Newborns Supplemented With Gentle-UHT Donor Milk
Lead Sponsor:
LactaLogics, Inc
Collaborating Sponsors:
Renown Regional Medical Center
Conditions:
Newborns
Breast Milk Expression
Eligibility:
All Genders
Up to 4 years
Phase:
NA
Brief Summary
This study evaluates the effects of providing breastfeeding mothers with Gentle-UHT donor human milk (GHM) after discharge to bridge the gap during delayed onset lactation, to support an exclusive hum...
Eligibility Criteria
Inclusion
- Gestational age \>36 weeks
- Exclusively fed human milk
- Age \<96 hours (4 days)
Exclusion
- Previous admittance to the neonatal intensive care unit
- Supplementation of any formula
Key Trial Info
Start Date :
August 3 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 17 2020
Estimated Enrollment :
31 Patients enrolled
Trial Details
Trial ID
NCT04492579
Start Date
August 3 2018
End Date
January 17 2020
Last Update
July 30 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
LactaLogics, Inc.
Port Saint Lucie, Florida, United States, 34952